36 related articles for article (PubMed ID: 11379818)
1. Antibody-Mediated Clearance of Brain Amyloid-β: Mechanisms of Action, Effects of Natural and Monoclonal Anti-Aβ Antibodies, and Downstream Effects.
Loeffler DA
J Alzheimers Dis Rep; 2023; 7(1):873-899. PubMed ID: 37662616
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's amyloid-β and tau protein accumulation is associated with decreased expression of the LDL receptor-associated protein in human brain tissue.
Shepherd CE; Affleck AJ; Bahar AY; Carew-Jones F; Gregory G; Small DH; Halliday GM
Brain Behav; 2020 Jul; 10(7):e01672. PubMed ID: 32484608
[TBL] [Abstract][Full Text] [Related]
3. Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease.
Alemi M; Silva SC; Santana I; Cardoso I
CNS Neurosci Ther; 2017 Jul; 23(7):605-619. PubMed ID: 28570028
[TBL] [Abstract][Full Text] [Related]
4. Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies.
Shinohara M; Tachibana M; Kanekiyo T; Bu G
J Lipid Res; 2017 Jul; 58(7):1267-1281. PubMed ID: 28381441
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
6. LRP1 Downregulates the Alzheimer's β-Secretase BACE1 by Modulating Its Intraneuronal Trafficking.
Tanokashira D; Motoki K; Minegishi S; Hosaka A; Mamada N; Tamaoka A; Okada T; Lakshmana MK; Araki W
eNeuro; 2015; 2(2):. PubMed ID: 26464978
[TBL] [Abstract][Full Text] [Related]
7. Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1.
Ramanathan A; Nelson AR; Sagare AP; Zlokovic BV
Front Aging Neurosci; 2015; 7():136. PubMed ID: 26236233
[TBL] [Abstract][Full Text] [Related]
8. LRP-1: functions, signaling and implications in kidney and other diseases.
Lin L; Hu K
Int J Mol Sci; 2014 Dec; 15(12):22887-901. PubMed ID: 25514242
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E isoform-specific effects on lipoprotein receptor processing.
Bachmeier C; Shackleton B; Ojo J; Paris D; Mullan M; Crawford F
Neuromolecular Med; 2014 Dec; 16(4):686-96. PubMed ID: 25015123
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.
Sagare AP; Deane R; Zlokovic BV
Pharmacol Ther; 2012 Oct; 136(1):94-105. PubMed ID: 22820095
[TBL] [Abstract][Full Text] [Related]
11. Association of ApoE and LRP mRNA levels with dementia and AD neuropathology.
Akram A; Schmeidler J; Katsel P; Hof PR; Haroutunian V
Neurobiol Aging; 2012 Mar; 33(3):628.e1-628.e14. PubMed ID: 21676498
[TBL] [Abstract][Full Text] [Related]
12. Alpha2-macroglobulin is a mediator of retinal ganglion cell death in glaucoma.
Shi Z; Rudzinski M; Meerovitch K; Lebrun-Julien F; Birman E; Di Polo A; Saragovi HU
J Biol Chem; 2008 Oct; 283(43):29156-65. PubMed ID: 18701465
[TBL] [Abstract][Full Text] [Related]
13. Sulfatides facilitate apolipoprotein E-mediated amyloid-beta peptide clearance through an endocytotic pathway.
Zeng Y; Han X
J Neurochem; 2008 Aug; 106(3):1275-86. PubMed ID: 18485101
[TBL] [Abstract][Full Text] [Related]
14. Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues.
Weeraratna AT; Kalehua A; Deleon I; Bertak D; Maher G; Wade MS; Lustig A; Becker KG; Wood W; Walker DG; Beach TG; Taub DD
Exp Cell Res; 2007 Feb; 313(3):450-61. PubMed ID: 17188679
[TBL] [Abstract][Full Text] [Related]
15. The generation and function of soluble apoE receptors in the CNS.
Rebeck GW; LaDu MJ; Estus S; Bu G; Weeber EJ
Mol Neurodegener; 2006 Oct; 1():15. PubMed ID: 17062143
[TBL] [Abstract][Full Text] [Related]
16. Modulation of beta-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family.
Cam JA; Bu G
Mol Neurodegener; 2006 Aug; 1():8. PubMed ID: 16930455
[TBL] [Abstract][Full Text] [Related]
17. Elevation of LDL receptor-related protein levels via ligand interactions in Alzheimer disease and in vitro.
Qiu Z; Strickland DK; Hyman BT; Rebeck GW
J Neuropathol Exp Neurol; 2001 May; 60(5):430-40. PubMed ID: 11379818
[TBL] [Abstract][Full Text] [Related]
18. Alpha2-macroglobulin enhances the clearance of endogenous soluble beta-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons.
Qiu Z; Strickland DK; Hyman BT; Rebeck GW
J Neurochem; 1999 Oct; 73(4):1393-8. PubMed ID: 10501182
[TBL] [Abstract][Full Text] [Related]
19. Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease.
Depboylu C; Lohmüller F; Du Y; Riemenschneider M; Kurz A; Gasser T; Müller U; Dodel RC
Neurosci Lett; 2006 Jun; 400(3):187-90. PubMed ID: 16650578
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
